InsidersTradesSigma
Follow the 泓博医药 stock price and the full directors' dealings record of the company, a publicly traded company based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 泓博医药 has published 2 public disclosures. Market capitalisation: €4.5bn. The latest transaction was disclosed on 30 December 2025 (Sale). Among the most active insiders: 泓博智源(香港)医药技术有限公司. All data is accessible without an account.
Analysts rate 泓博医药 Strong Buy (bullish).
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
2 of 2 declarations
泓博医药 es una empresa especializada en el sector de la salud y farmacéutico. Cotiza en el mercado XSHE.